Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05271240
Title Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Northwell Health
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Lenox Hill Brain Tumor Center RECRUITING New York New York 10075 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field